Cecilie Boysen
About Cecilie Boysen
Cecilie Boysen serves as the Scientific Director of Customer Success at DNAnexus, bringing extensive expertise in bioinformatics and molecular biology. She has held various roles in prominent organizations, contributing to advancements in genomics and cancer therapies.
Current Role at DNAnexus
Cecilie Boysen serves as the Scientific Director of Customer Success at DNAnexus since 2021. In this role, she focuses on ensuring customer satisfaction and success through the application of advanced bioinformatics solutions. Her expertise in genomics and bioinformatics supports the company's mission to enhance data-driven decision-making in life sciences.
Previous Experience in Bioinformatics and Research
Cecilie Boysen has a diverse background in bioinformatics and research. She worked as a Senior Scientist and Bioinformatician at MEDomics for eight months in 2010. Prior to that, she held the position of Research Fellow at Lundbeck from 1997 to 2000 for three years. Additionally, she served as Director of Geneious Biologics Solutions at Biomatters from 2018 to 2019.
Educational Background in Biochemistry and Biology
Cecilie Boysen studied at Københavns Universitet - University of Copenhagen, where she earned a Cand. Scient. in Biochemistry from 1984 to 1990. She furthered her education at Caltech, obtaining a Ph.D. in Biology from 1991 to 1996. This strong educational foundation supports her extensive work in the fields of genomics and bioinformatics.
Expertise in Genomics and Molecular Biology
Cecilie Boysen has developed PCR-based and DNA sequencing technologies and bioinformatics software, contributing to advancements in genomics and functional genomics. She has extensive experience in adaptive TCR T-cell therapies targeting cancer neo-epitopes and has been involved in developing bioinformatics solutions for various sequencing technologies, including Single Cell and RNASeq.
Regulatory Compliance and Laboratory Management
Cecilie Boysen has experience in establishing molecular biology laboratories from the ground up, ensuring compliance with CLIA, CAP, and HIPAA regulations. She has collaborated with organizations such as the FDA, NIST, and DOD, demonstrating her capability in navigating complex regulatory environments in the life sciences sector.